These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14656419)

  • 1. Ganciclovir therapy in cytomegalovirus (CMV) infection in immunocompetent pediatric patients.
    Avila-Agüero ML; Paris MM; Alfaro W; Avila-Agüero CR; Faingezicht I
    Int J Infect Dis; 2003 Dec; 7(4):278-81. PubMed ID: 14656419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation.
    Ju HY; Kang HJ; Hong CR; Lee JW; Kim H; Park KD; Shin HY; Park JD; Choi EH; Lee HJ; Ahn HS
    Transpl Infect Dis; 2016 Jun; 18(3):396-404. PubMed ID: 27041364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, controlled trial.
    Singh N; Paterson DL; Gayowski T; Wagener MM; Marino IR
    Transplantation; 2000 Sep; 70(5):717-22. PubMed ID: 11003347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children.
    Nigro G; Krzysztofiak A; Bartmann U; Clerico A; Properzi E; Valia S; Castello M
    Arch Virol; 1997; 142(3):573-80. PubMed ID: 9349303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus encephalitis in immunocompetent infants: A 15-year retrospective study at a single center.
    Guo Y; Jiang L
    Int J Infect Dis; 2019 May; 82():106-110. PubMed ID: 30844517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.
    Murray BM; Subramaniam S
    Transpl Infect Dis; 2004 Mar; 6(1):3-9. PubMed ID: 15225220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia.
    Gotti E; Suter F; Baruzzo S; Perani V; Moioli F; Remuzzi G
    Clin Transplant; 1996 Dec; 10(6 Pt 1):550-5. PubMed ID: 8996777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of CMV disease in allogeneic BMT recipients by cytomegalovirus antigenemia-guided preemptive ganciclovir therapy.
    Koehler M; St George K; Ehrlich GD; Mirro J; Neudorf SM; Rinaldo C
    J Pediatr Hematol Oncol; 1997; 19(1):43-7. PubMed ID: 9065718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A universal preemptive therapy for cytomegalovirus infections in children after live-donor liver transplantation.
    Saitoh A; Sakamoto S; Fukuda A; Shigeta T; Kakiuchi T; Kamiyama S; Katsuta T; Shoji K; Ogimi C; Kasahara M
    Transplantation; 2011 Oct; 92(8):930-5. PubMed ID: 21941226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir.
    Laurenti L; Piccioni P; Cattani P; Cingolani A; Efremov D; Chiusolo P; Tarnani M; Fadda G; Sica S; Leone G
    Haematologica; 2004 Oct; 89(10):1248-52. PubMed ID: 15477211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation.
    Bacigalupo A; Bregante S; Tedone E; Isaza A; Van Lint MT; Trespi G; Occhini D; Gualandi F; Lamparelli T; Marmont AM
    Transplantation; 1996 Aug; 62(3):376-80. PubMed ID: 8779686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment.
    Hazar V; Ugur A; Colak D; Saba R; Tezcan G; Kupesiz A; Karadogan I; Gultekin M; Yesilipek A; Undar L
    Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides.
    Sakamoto K; Nakasone H; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Ashizawa M; Sato M; Terasako-Saito K; Machishima T; Kimura S; Kikuchi M; Kako S; Kanda J; Yamazaki R; Tanihara A; Nishida J; Kanda Y
    PLoS One; 2013; 8(9):e73754. PubMed ID: 24040054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status.
    Inokuchi T; Kato J; Hiraoka S; Suzuki H; Nakarai A; Hirakawa T; Akita M; Takahashi S; Harada K; Okada H; Yamamoto K
    World J Gastroenterol; 2014 Jan; 20(2):509-17. PubMed ID: 24574719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy preemptive therapy with ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients].
    López-Medrano F; Lumbreras C; Otero JR; González-Alegre MT; San Juan R; Folgueira D; Lizasoaín M; Loinaz C; Moreno E; Aguado JM
    Med Clin (Barc); 2004 Jan; 122(2):41-5. PubMed ID: 14733853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum polymerase chain reaction for cytomegalovirus DNA for monitoring ganciclovir treatment in AIDS patients.
    Marenzi R; Cinque P; Ceresa D; Racca S; Lillo F; Lazzarin A
    Scand J Infect Dis; 1996; 28(4):347-51. PubMed ID: 8893396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitions of cytomegalovirus disease after heart transplantation: antigenemia as a marker for antiviral therapy.
    Iberer F; Tscheliessnigg K; Halwachs G; Rehak P; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayer T; Freigassner M; Prenner G; Hipmair G; Grasser B
    Transpl Int; 1996; 9(3):236-42. PubMed ID: 8723193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients.
    Humar A; Lipton J; Welsh S; Moussa G; Messner H; Mazzulli T
    Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.